位置:首页 > 蛋白库 > VIP2_MOUSE
VIP2_MOUSE
ID   VIP2_MOUSE              Reviewed;        1129 AA.
AC   Q6ZQB6; E9PVE9; Q3TM75; Q3UUA3; Q7TPU4;
DT   15-JAN-2008, integrated into UniProtKB/Swiss-Prot.
DT   27-JUL-2011, sequence version 3.
DT   03-AUG-2022, entry version 122.
DE   RecName: Full=Inositol hexakisphosphate and diphosphoinositol-pentakisphosphate kinase 2 {ECO:0000305};
DE            EC=2.7.4.24 {ECO:0000269|PubMed:17690096};
DE   AltName: Full=Diphosphoinositol pentakisphosphate kinase 2;
DE   AltName: Full=Histidine acid phosphatase domain-containing protein 1;
DE   AltName: Full=InsP6 and PP-IP5 kinase 2;
DE   AltName: Full=VIP1 homolog 2;
DE            Short=mmVIP2;
GN   Name=Ppip5k2 {ECO:0000303|PubMed:29590114, ECO:0000312|MGI:MGI:2142810};
GN   Synonyms=Hisppd1, Kiaa0433, Vip2;
OS   Mus musculus (Mouse).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Glires; Rodentia; Myomorpha; Muroidea; Muridae;
OC   Murinae; Mus; Mus.
OX   NCBI_TaxID=10090;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1).
RC   TISSUE=Embryonic tail;
RX   PubMed=14621295; DOI=10.1093/dnares/10.4.167;
RA   Okazaki N., Kikuno R., Ohara R., Inamoto S., Koseki H., Hiraoka S.,
RA   Saga Y., Nagase T., Ohara O., Koga H.;
RT   "Prediction of the coding sequences of mouse homologues of KIAA gene: III.
RT   The complete nucleotide sequences of 500 mouse KIAA-homologous cDNAs
RT   identified by screening of terminal sequences of cDNA clones randomly
RT   sampled from size-fractionated libraries.";
RL   DNA Res. 10:167-180(2003).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 2).
RC   STRAIN=C57BL/6J; TISSUE=Lung, and Spinal cord;
RX   PubMed=16141072; DOI=10.1126/science.1112014;
RA   Carninci P., Kasukawa T., Katayama S., Gough J., Frith M.C., Maeda N.,
RA   Oyama R., Ravasi T., Lenhard B., Wells C., Kodzius R., Shimokawa K.,
RA   Bajic V.B., Brenner S.E., Batalov S., Forrest A.R., Zavolan M., Davis M.J.,
RA   Wilming L.G., Aidinis V., Allen J.E., Ambesi-Impiombato A., Apweiler R.,
RA   Aturaliya R.N., Bailey T.L., Bansal M., Baxter L., Beisel K.W., Bersano T.,
RA   Bono H., Chalk A.M., Chiu K.P., Choudhary V., Christoffels A.,
RA   Clutterbuck D.R., Crowe M.L., Dalla E., Dalrymple B.P., de Bono B.,
RA   Della Gatta G., di Bernardo D., Down T., Engstrom P., Fagiolini M.,
RA   Faulkner G., Fletcher C.F., Fukushima T., Furuno M., Futaki S.,
RA   Gariboldi M., Georgii-Hemming P., Gingeras T.R., Gojobori T., Green R.E.,
RA   Gustincich S., Harbers M., Hayashi Y., Hensch T.K., Hirokawa N., Hill D.,
RA   Huminiecki L., Iacono M., Ikeo K., Iwama A., Ishikawa T., Jakt M.,
RA   Kanapin A., Katoh M., Kawasawa Y., Kelso J., Kitamura H., Kitano H.,
RA   Kollias G., Krishnan S.P., Kruger A., Kummerfeld S.K., Kurochkin I.V.,
RA   Lareau L.F., Lazarevic D., Lipovich L., Liu J., Liuni S., McWilliam S.,
RA   Madan Babu M., Madera M., Marchionni L., Matsuda H., Matsuzawa S., Miki H.,
RA   Mignone F., Miyake S., Morris K., Mottagui-Tabar S., Mulder N., Nakano N.,
RA   Nakauchi H., Ng P., Nilsson R., Nishiguchi S., Nishikawa S., Nori F.,
RA   Ohara O., Okazaki Y., Orlando V., Pang K.C., Pavan W.J., Pavesi G.,
RA   Pesole G., Petrovsky N., Piazza S., Reed J., Reid J.F., Ring B.Z.,
RA   Ringwald M., Rost B., Ruan Y., Salzberg S.L., Sandelin A., Schneider C.,
RA   Schoenbach C., Sekiguchi K., Semple C.A., Seno S., Sessa L., Sheng Y.,
RA   Shibata Y., Shimada H., Shimada K., Silva D., Sinclair B., Sperling S.,
RA   Stupka E., Sugiura K., Sultana R., Takenaka Y., Taki K., Tammoja K.,
RA   Tan S.L., Tang S., Taylor M.S., Tegner J., Teichmann S.A., Ueda H.R.,
RA   van Nimwegen E., Verardo R., Wei C.L., Yagi K., Yamanishi H.,
RA   Zabarovsky E., Zhu S., Zimmer A., Hide W., Bult C., Grimmond S.M.,
RA   Teasdale R.D., Liu E.T., Brusic V., Quackenbush J., Wahlestedt C.,
RA   Mattick J.S., Hume D.A., Kai C., Sasaki D., Tomaru Y., Fukuda S.,
RA   Kanamori-Katayama M., Suzuki M., Aoki J., Arakawa T., Iida J., Imamura K.,
RA   Itoh M., Kato T., Kawaji H., Kawagashira N., Kawashima T., Kojima M.,
RA   Kondo S., Konno H., Nakano K., Ninomiya N., Nishio T., Okada M., Plessy C.,
RA   Shibata K., Shiraki T., Suzuki S., Tagami M., Waki K., Watahiki A.,
RA   Okamura-Oho Y., Suzuki H., Kawai J., Hayashizaki Y.;
RT   "The transcriptional landscape of the mammalian genome.";
RL   Science 309:1559-1563(2005).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RC   STRAIN=C57BL/6J;
RX   PubMed=19468303; DOI=10.1371/journal.pbio.1000112;
RA   Church D.M., Goodstadt L., Hillier L.W., Zody M.C., Goldstein S., She X.,
RA   Bult C.J., Agarwala R., Cherry J.L., DiCuccio M., Hlavina W., Kapustin Y.,
RA   Meric P., Maglott D., Birtle Z., Marques A.C., Graves T., Zhou S.,
RA   Teague B., Potamousis K., Churas C., Place M., Herschleb J., Runnheim R.,
RA   Forrest D., Amos-Landgraf J., Schwartz D.C., Cheng Z., Lindblad-Toh K.,
RA   Eichler E.E., Ponting C.P.;
RT   "Lineage-specific biology revealed by a finished genome assembly of the
RT   mouse.";
RL   PLoS Biol. 7:E1000112-E1000112(2009).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 3).
RC   STRAIN=C57BL/6J; TISSUE=Egg;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA project:
RT   the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [5]
RP   FUNCTION, ENZYME ACTIVITY, AND BIOPHYSICOCHEMICAL PROPERTIES.
RX   PubMed=17690096; DOI=10.1074/jbc.m704656200;
RA   Fridy P.C., Otto J.C., Dollins D.E., York J.D.;
RT   "Cloning and characterization of two human VIP1-like inositol
RT   hexakisphosphate and diphosphoinositol pentakisphosphate kinases.";
RL   J. Biol. Chem. 282:30754-30762(2007).
RN   [6]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=19144319; DOI=10.1016/j.immuni.2008.11.006;
RA   Trost M., English L., Lemieux S., Courcelles M., Desjardins M.,
RA   Thibault P.;
RT   "The phagosomal proteome in interferon-gamma-activated macrophages.";
RL   Immunity 30:143-154(2009).
RN   [7]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-44 AND SER-1066, AND
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Brown adipose tissue, Heart, Liver, Lung, Pancreas, Spleen, and
RC   Testis;
RX   PubMed=21183079; DOI=10.1016/j.cell.2010.12.001;
RA   Huttlin E.L., Jedrychowski M.P., Elias J.E., Goswami T., Rad R.,
RA   Beausoleil S.A., Villen J., Haas W., Sowa M.E., Gygi S.P.;
RT   "A tissue-specific atlas of mouse protein phosphorylation and expression.";
RL   Cell 143:1174-1189(2010).
RN   [8]
RP   FUNCTION, AND TISSUE SPECIFICITY.
RX   PubMed=29590114; DOI=10.1371/journal.pgen.1007297;
RA   Yousaf R., Gu C., Ahmed Z.M., Khan S.N., Friedman T.B., Riazuddin S.,
RA   Shears S.B., Riazuddin S.;
RT   "Mutations in Diphosphoinositol-Pentakisphosphate Kinase PPIP5K2 are
RT   associated with hearing loss in human and mouse.";
RL   PLoS Genet. 14:E1007297-E1007297(2018).
CC   -!- FUNCTION: Bifunctional inositol kinase that acts in concert with the
CC       IP6K kinases IP6K1, IP6K2 and IP6K3 to synthesize the diphosphate
CC       group-containing inositol pyrophosphates diphosphoinositol
CC       pentakisphosphate, PP-InsP5, and bis-diphosphoinositol
CC       tetrakisphosphate, (PP)2-InsP4 (PubMed:17690096). PP-InsP5 and (PP)2-
CC       InsP4, also respectively called InsP7 and InsP8, regulate a variety of
CC       cellular processes, including apoptosis, vesicle trafficking,
CC       cytoskeletal dynamics, exocytosis, insulin signaling and neutrophil
CC       activation (PubMed:17690096). Phosphorylates inositol hexakisphosphate
CC       (InsP6) at position 1 to produce PP-InsP5 which is in turn
CC       phosphorylated by IP6Ks to produce (PP)2-InsP4 (PubMed:17690096).
CC       Alternatively, phosphorylates PP-InsP5 at position 1, produced by IP6Ks
CC       from InsP6, to produce (PP)2-InsP4 (PubMed:17690096). Required for
CC       normal hearing (PubMed:29590114). {ECO:0000269|PubMed:17690096,
CC       ECO:0000269|PubMed:29590114}.
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=1D-myo-inositol hexakisphosphate + ATP = 1-diphospho-myo-
CC         inositol 2,3,4,5,6-pentakisphosphate + ADP; Xref=Rhea:RHEA:37459,
CC         ChEBI:CHEBI:30616, ChEBI:CHEBI:58130, ChEBI:CHEBI:74946,
CC         ChEBI:CHEBI:456216; EC=2.7.4.24;
CC         Evidence={ECO:0000269|PubMed:17690096};
CC       PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:37460;
CC         Evidence={ECO:0000305|PubMed:17690096};
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=5-diphospho-1D-myo-inositol 1,2,3,4,6-pentakisphosphate + ATP
CC         + H(+) = 1,5-bis(diphospho)-1D-myo-inositol 2,3,4,6-tetrakisphosphate
CC         + ADP; Xref=Rhea:RHEA:10276, ChEBI:CHEBI:15378, ChEBI:CHEBI:30616,
CC         ChEBI:CHEBI:58628, ChEBI:CHEBI:77983, ChEBI:CHEBI:456216;
CC         EC=2.7.4.24; Evidence={ECO:0000269|PubMed:17690096};
CC       PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:10277;
CC         Evidence={ECO:0000305|PubMed:17690096};
CC   -!- BIOPHYSICOCHEMICAL PROPERTIES:
CC       Kinetic parameters:
CC         KM=0.23 uM for InsP6 {ECO:0000269|PubMed:17690096};
CC         KM=0.54 uM for InsP7 {ECO:0000269|PubMed:17690096};
CC         Vmax=1.70 nmol/min/mg enzyme with InsP6 as substrate
CC         {ECO:0000269|PubMed:17690096};
CC         Vmax=5.23 nmol/min/mg enzyme with InsP7 as substrate
CC         {ECO:0000269|PubMed:17690096};
CC   -!- SUBCELLULAR LOCATION: Cytoplasm, cytosol
CC       {ECO:0000250|UniProtKB:O43314}.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=3;
CC       Name=1;
CC         IsoId=Q6ZQB6-1; Sequence=Displayed;
CC       Name=2;
CC         IsoId=Q6ZQB6-2; Sequence=VSP_030637, VSP_030638;
CC       Name=3;
CC         IsoId=Q6ZQB6-3; Sequence=VSP_041618;
CC   -!- TISSUE SPECIFICITY: Ubiquitously expressed (PubMed:29590114). Expressed
CC       in the cochlear and vestibular sensory hair cells, supporting cells and
CC       spiral ganglion neurons (PubMed:29590114).
CC       {ECO:0000269|PubMed:29590114}.
CC   -!- DOMAIN: The C-terminal acid phosphatase-like domain binds
CC       PtdIns(3,4,5)P3 and InsP6. Despite its similarity with the phosphatase
CC       domain of histidine acid phosphatases, it has no phosphatase activity.
CC       {ECO:0000250|UniProtKB:O43314}.
CC   -!- SIMILARITY: Belongs to the histidine acid phosphatase family. VIP1
CC       subfamily. {ECO:0000305}.
CC   -!- SEQUENCE CAUTION:
CC       Sequence=BAC97950.1; Type=Erroneous initiation; Note=Extended N-terminus.; Evidence={ECO:0000305};
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; AK129140; BAC97950.1; ALT_INIT; mRNA.
DR   EMBL; AK138622; BAE23724.1; -; mRNA.
DR   EMBL; AK166095; BAE38567.1; -; mRNA.
DR   EMBL; AC099860; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AC162298; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; BC053396; AAH53396.1; -; mRNA.
DR   CCDS; CCDS35678.2; -. [Q6ZQB6-1]
DR   RefSeq; NP_776121.4; NM_173760.5. [Q6ZQB6-1]
DR   AlphaFoldDB; Q6ZQB6; -.
DR   SMR; Q6ZQB6; -.
DR   STRING; 10090.ENSMUSP00000108466; -.
DR   iPTMnet; Q6ZQB6; -.
DR   PhosphoSitePlus; Q6ZQB6; -.
DR   EPD; Q6ZQB6; -.
DR   jPOST; Q6ZQB6; -.
DR   MaxQB; Q6ZQB6; -.
DR   PaxDb; Q6ZQB6; -.
DR   PeptideAtlas; Q6ZQB6; -.
DR   PRIDE; Q6ZQB6; -.
DR   ProteomicsDB; 297919; -. [Q6ZQB6-1]
DR   ProteomicsDB; 297920; -. [Q6ZQB6-2]
DR   ProteomicsDB; 297921; -. [Q6ZQB6-3]
DR   Antibodypedia; 44750; 78 antibodies from 20 providers.
DR   Ensembl; ENSMUST00000042509; ENSMUSP00000043401; ENSMUSG00000040648. [Q6ZQB6-1]
DR   Ensembl; ENSMUST00000171129; ENSMUSP00000132889; ENSMUSG00000040648. [Q6ZQB6-3]
DR   GeneID; 227399; -.
DR   KEGG; mmu:227399; -.
DR   UCSC; uc007cfk.4; mouse. [Q6ZQB6-1]
DR   UCSC; uc007cfl.1; mouse. [Q6ZQB6-2]
DR   CTD; 23262; -.
DR   MGI; MGI:2142810; Ppip5k2.
DR   VEuPathDB; HostDB:ENSMUSG00000040648; -.
DR   eggNOG; KOG1057; Eukaryota.
DR   GeneTree; ENSGT00390000009048; -.
DR   HOGENOM; CLU_000914_0_0_1; -.
DR   InParanoid; Q6ZQB6; -.
DR   OMA; YLAHIVI; -.
DR   OrthoDB; 93740at2759; -.
DR   BRENDA; 2.7.4.21; 3474.
DR   BRENDA; 2.7.4.24; 3474.
DR   Reactome; R-MMU-1855167; Synthesis of pyrophosphates in the cytosol.
DR   SABIO-RK; Q6ZQB6; -.
DR   BioGRID-ORCS; 227399; 5 hits in 56 CRISPR screens.
DR   PRO; PR:Q6ZQB6; -.
DR   Proteomes; UP000000589; Chromosome 1.
DR   RNAct; Q6ZQB6; protein.
DR   Bgee; ENSMUSG00000040648; Expressed in manus and 256 other tissues.
DR   ExpressionAtlas; Q6ZQB6; baseline and differential.
DR   Genevisible; Q6ZQB6; MM.
DR   GO; GO:0005829; C:cytosol; ISS:UniProtKB.
DR   GO; GO:0102092; F:5-diphosphoinositol pentakisphosphate 3-kinase activity; IEA:UniProtKB-EC.
DR   GO; GO:0005524; F:ATP binding; ISS:UniProtKB.
DR   GO; GO:0033857; F:diphosphoinositol-pentakisphosphate kinase activity; IDA:MGI.
DR   GO; GO:0000829; F:inositol heptakisphosphate kinase activity; IBA:GO_Central.
DR   GO; GO:0052723; F:inositol hexakisphosphate 1-kinase activity; IEA:UniProtKB-EC.
DR   GO; GO:0052724; F:inositol hexakisphosphate 3-kinase activity; IEA:UniProtKB-EC.
DR   GO; GO:0000832; F:inositol hexakisphosphate 5-kinase activity; ISS:UniProtKB.
DR   GO; GO:0000828; F:inositol hexakisphosphate kinase activity; IDA:MGI.
DR   GO; GO:0000827; F:inositol-1,3,4,5,6-pentakisphosphate kinase activity; ISS:UniProtKB.
DR   GO; GO:0006020; P:inositol metabolic process; ISS:UniProtKB.
DR   GO; GO:0032958; P:inositol phosphate biosynthetic process; IBA:GO_Central.
DR   GO; GO:0016310; P:phosphorylation; IEA:UniProtKB-KW.
DR   GO; GO:0007605; P:sensory perception of sound; IEA:UniProtKB-KW.
DR   CDD; cd07061; HP_HAP_like; 1.
DR   Gene3D; 3.40.50.1240; -; 1.
DR   InterPro; IPR033379; Acid_Pase_AS.
DR   InterPro; IPR000560; His_Pase_clade-2.
DR   InterPro; IPR037446; His_Pase_VIP1.
DR   InterPro; IPR029033; His_PPase_superfam.
DR   InterPro; IPR040557; VIP1_N.
DR   PANTHER; PTHR12750; PTHR12750; 2.
DR   Pfam; PF00328; His_Phos_2; 1.
DR   Pfam; PF18086; PPIP5K2_N; 1.
DR   SUPFAM; SSF53254; SSF53254; 1.
DR   PROSITE; PS00616; HIS_ACID_PHOSPHAT_1; 1.
PE   1: Evidence at protein level;
KW   Alternative splicing; ATP-binding; Cytoplasm; Hearing; Kinase;
KW   Nucleotide-binding; Phosphoprotein; Reference proteome; Transferase.
FT   CHAIN           1..1129
FT                   /note="Inositol hexakisphosphate and diphosphoinositol-
FT                   pentakisphosphate kinase 2"
FT                   /id="PRO_0000315693"
FT   REGION          377..448
FT                   /note="Polyphosphoinositide-binding domain"
FT                   /evidence="ECO:0000250|UniProtKB:O43314"
FT   REGION          904..945
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          1070..1129
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        922..945
FT                   /note="Basic and acidic residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   BINDING         59..60
FT                   /ligand="substrate"
FT                   /evidence="ECO:0000250|UniProtKB:O43314"
FT   BINDING         140
FT                   /ligand="ATP"
FT                   /ligand_id="ChEBI:CHEBI:30616"
FT                   /evidence="ECO:0000250|UniProtKB:O43314"
FT   BINDING         193
FT                   /ligand="ATP"
FT                   /ligand_id="ChEBI:CHEBI:30616"
FT                   /evidence="ECO:0000250|UniProtKB:O43314"
FT   BINDING         200
FT                   /ligand="ATP"
FT                   /ligand_id="ChEBI:CHEBI:30616"
FT                   /evidence="ECO:0000250|UniProtKB:O43314"
FT   BINDING         219..220
FT                   /ligand="substrate"
FT                   /evidence="ECO:0000250|UniProtKB:O43314"
FT   BINDING         219
FT                   /ligand="ATP"
FT                   /ligand_id="ChEBI:CHEBI:30616"
FT                   /evidence="ECO:0000250|UniProtKB:O43314"
FT   BINDING         243..246
FT                   /ligand="ATP"
FT                   /ligand_id="ChEBI:CHEBI:30616"
FT                   /evidence="ECO:0000250|UniProtKB:O43314"
FT   BINDING         252..254
FT                   /ligand="ATP"
FT                   /ligand_id="ChEBI:CHEBI:30616"
FT                   /evidence="ECO:0000250|UniProtKB:O43314"
FT   BINDING         254
FT                   /ligand="substrate"
FT                   /evidence="ECO:0000250|UniProtKB:O43314"
FT   BINDING         268
FT                   /ligand="substrate"
FT                   /evidence="ECO:0000250|UniProtKB:O43314"
FT   BINDING         270
FT                   /ligand="ATP"
FT                   /ligand_id="ChEBI:CHEBI:30616"
FT                   /evidence="ECO:0000250|UniProtKB:O43314"
FT   BINDING         315
FT                   /ligand="ATP"
FT                   /ligand_id="ChEBI:CHEBI:30616"
FT                   /evidence="ECO:0000250|UniProtKB:O43314"
FT   BINDING         327..329
FT                   /ligand="ATP"
FT                   /ligand_id="ChEBI:CHEBI:30616"
FT                   /evidence="ECO:0000250|UniProtKB:O43314"
FT   BINDING         332..335
FT                   /ligand="substrate"
FT                   /evidence="ECO:0000250|UniProtKB:O43314"
FT   MOD_RES         44
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:21183079"
FT   MOD_RES         229
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:O43314"
FT   MOD_RES         1051
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:O43314"
FT   MOD_RES         1058
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:O43314"
FT   MOD_RES         1066
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:21183079"
FT   MOD_RES         1106
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:O43314"
FT   MOD_RES         1107
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:O43314"
FT   VAR_SEQ         1..6
FT                   /note="Missing (in isoform 3)"
FT                   /evidence="ECO:0000303|PubMed:15489334"
FT                   /id="VSP_041618"
FT   VAR_SEQ         545
FT                   /note="Missing (in isoform 2)"
FT                   /evidence="ECO:0000303|PubMed:16141072"
FT                   /id="VSP_030637"
FT   VAR_SEQ         1051..1129
FT                   /note="SSMATRSSPGMRRKISLNTYTPTKILPTPPAALKSSKASSKAAAGGPSQAMA
FT                   PHTSSRKKSINSKTEGHEPKKSTGKKR -> CMEFTFIVT (in isoform 2)"
FT                   /evidence="ECO:0000303|PubMed:16141072"
FT                   /id="VSP_030638"
FT   CONFLICT        197
FT                   /note="A -> V (in Ref. 1; BAE38567)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        582
FT                   /note="A -> T (in Ref. 4; AAH53396)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        729
FT                   /note="I -> V (in Ref. 4; AAH53396)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        1035
FT                   /note="S -> P (in Ref. 4; AAH53396)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        1109
FT                   /note="K -> M (in Ref. 1; BAC97950)"
FT                   /evidence="ECO:0000305"
SQ   SEQUENCE   1129 AA;  128427 MW;  A563826CC0085E3C CRC64;
     MSNSRKMSEP PRFFVGPEDA EINPGNYRRF FHHAEEEEEE EDESPPERQI VVGICSMAKK
     SKSKPMKEIL ERISLFKYIT VVVFEEEIIL NEPVENWPLC DCLISFHSKG FPLDKAVAYA
     KLRNPFVIND LNMQYLIQDR RDVYSILQAE GILLPRYAIL NRDPNNPKEC NLIEGEDHVE
     VNGEVFQKPF VEKPVSAEDH NVYIYYPTSA GGGSQRLFRK IGSRSSVYSP ESNVRKTGSY
     IYEEFMPTDG TDVKVYTVGP DYAHAEARKS PALDGKVERD SEGKEVRYPV ILNAREKLIA
     WKVCLAFKQT VCGFDLLRAN GQSYVCDVNG FSFVKNSMKY YDDCAKILGN IVMRELAPQF
     HIPWSIPLEA EDIPIVPTTS GTMMELRCVI AVIRHGDRTP KQKMKMEVRH QKFFDLFEKC
     DGYKSGKLKL KKPKQLQEVL DIARQLLMEL GQNNDSEIEE NKSKLEQLKT VLEMYGHFSG
     INRKVQLTYL PHGCPKTSSE EEDNRREEPS LLLVLKWGGE LTPAGRVQAE ELGRAFRCMY
     PGGQGDYAGF PGCGLLRLHS TYRHDLKIYA SDEGRVQMTA AAFAKGLLAL EGELTPILVQ
     MVKSANMNGL LDSDSDSLSS CQQRVKARLH EILQKDRDFT AEDYEKLTPS GSISVIKSMH
     LIKNPVKTCD KVYSLIQSLT SQIRYRMEDP KSADIQLYHS ETLELMLRRW SKLEKDFKTK
     NGRYDISKIP DIYDCIKYDV QHNGSLKLEN TMELYRLSKA LADIVIPQEY GITKAEKLEI
     AKGYCTPLVR KIRSDLQRTQ DDDTVNKLHP VYSRGVLSPE RHVRTRLYFT SESHVHSLLS
     ILRYGALCDD SKDEQWKRAM DYLNVVNELN YMTQIVIMLY EDPNKDLSSE ERFHVELHFS
     PGAKGCEEDK NLPSGYGYRP ASRENEGRRS LKTDDDEPHT SKRDEVDRAV MLFKPLVSEP
     IHIHRKSPLP RSRKITANEV VSENANYLRT PRNLVEQKQN PTVGFELYSM VPSICPLETL
     HNALFLKQVD DFLASIASPS TEVLRKVPEM SSMATRSSPG MRRKISLNTY TPTKILPTPP
     AALKSSKASS KAAAGGPSQA MAPHTSSRKK SINSKTEGHE PKKSTGKKR
 
 
维奥蛋白资源库 - 中文蛋白资源 CopyRight © 2010-2024